Uz Stammberger

Chief Medical Officer

Uz joined Prokarium in 2021 from the Novartis Institutes for BioMedical Research, where he oversaw the MAPK assets in Translational Clinical Oncology and generated several PoCs/PoMs in different genetically defined solid tumors. Prior to his role at Novartis, Uz was a Clinical Lead at Merck KGaA, responsible for Tepotinib, a small molecule inhib...


Roles at Prokarium

  • Chief Medical Officer

    January, 2021 - present

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.